Contribution of fasting and postprandial hyperglycemia to hemoglobin A1c in insulin-treated Japanese diabetic patients

被引:21
作者
Shimizu, Hiroyuki [1 ]
Uehara, Yutaka [1 ]
Okada, Shuici [1 ]
Mori, Masatomo [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 3718511, Japan
关键词
hemoglobin A(1c); insulin; postprandial hyperglycemia; diabetes mellitus;
D O I
10.1507/endocrj.K07E-142
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The contribution of fasting and postprandial glucose to hemoglobin A(1c) (HbA(1c)) levels was evaluated in insulin-treated patients. In 57 insulin-treated, diabetic out-patients, fasting glucose (before breakfast (B-FG), lunch (L-FG) and dinner (D-FG,)) and postprandial glucose (B-PPG, L-PPG and D-PPG) levels were determined by the patients themselves at home using glucose self-monitoring apparatus over the course of one week. The correlation between HbA(1c) levels and self monitored blood glucose levels were calculated. In the conventionally treated group, there was a significant correlation between HbA(1c) and fasting glucose (FG) levels only before lunch, but at 2 hr after (PPG) all meals. In the intensively treated group, a significant correlation between HbA(1c) levels and FG levels was found before lunch and at 2 hr after breakfast and dinner. In all subjects, only FG levels before lunch correlated significantly with HbA(1c) levels, although PPG levels were significantly correlated with HbA(1c) at all points. The correlation was highest with PPG after breakfast and dinner. The sum of all FG, PPG and FG + PPG levels was significantly correlated with HbA(1c) levels. Postprandial hyperglycemia after breakfast and dinner should be regarded as most important for improving HbA(1c) levels in insulin treated diabetic patients.
引用
收藏
页码:753 / 756
页数:4
相关论文
共 8 条
[1]  
Kahn R, 2001, DIABETES CARE, V24, P775
[2]   Starting insulin therapy in type 2 diabetes: Twice-daily biphasic insulin aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride [J].
Kann, P. H. ;
Wascher, T. ;
Zackova, V. ;
Moeller, J. ;
Medding, J. ;
Szocs, A. ;
Mokan, M. ;
Mrevlje, F. ;
Regulski, M. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (09) :527-532
[3]   Association of hemoglobin A1c with cardiovascular disease and mortality in adults:: The European prospective investigation into cancer in Norfolk [J].
Khaw, KT ;
Wareham, N ;
Bingham, S ;
Luben, R ;
Welch, A ;
Day, N .
ANNALS OF INTERNAL MEDICINE, 2004, 141 (06) :413-420
[4]   Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients -: Variations with increasing levels of HbA1c [J].
Monnier, L ;
Lapinski, H ;
Colette, C .
DIABETES CARE, 2003, 26 (03) :881-885
[5]  
Monnier Louis, 2006, Endocr Pract, V12 Suppl 1, P42
[6]   Relationship between HbA1c and indices of glucose tolerance derived from a standardized meal test in newly diagnosed treatment naive subjects with Type 2 diabetes [J].
Peter, R. ;
Luzio, S. D. ;
Dunseath, G. ;
Pauvaday, V. ;
Mustafa, N. ;
Owens, D. R. .
DIABETIC MEDICINE, 2006, 23 (09) :990-995
[7]   Initiating insulin therapy in type 2 diabetes - A comparison of biphasic and basal insulin analogs [J].
Raskin, P ;
Hu, P ;
Allen, E ;
Bode, B ;
Hollander, P ;
Garber, A ;
Lewin, A ;
Gabbay, RA .
DIABETES CARE, 2005, 28 (02) :260-265
[8]   United Kingdom prospective diabetes study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus [J].
Turner, R ;
Cull, C ;
Holman, R .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (01) :136-145